TITAN PHARMACEUTICALS INC DE's ticker is TTNP and the CUSIP is 888314309. A total of 37 filers reported holding TITAN PHARMACEUTICALS INC DE in Q3 2018. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2018 | $3,000 | 0.0% | 12,828 | 0.0% | 0.00% | – |
| Q3 2018 | $3,000 | -78.6% | 12,828 | 0.0% | 0.00% | – |
| Q2 2018 | $14,000 | -17.6% | 12,828 | -22.3% | 0.00% | – |
| Q1 2018 | $17,000 | -5.6% | 16,500 | +23.8% | 0.00% | – |
| Q4 2017 | $18,000 | -18.2% | 13,328 | +3.9% | 0.00% | – |
| Q3 2017 | $22,000 | -8.3% | 12,828 | 0.0% | 0.00% | – |
| Q2 2017 | $24,000 | -88.3% | 12,828 | -79.4% | 0.00% | – |
| Q1 2017 | $206,000 | -17.3% | 62,270 | -0.1% | 0.00% | – |
| Q4 2016 | $249,000 | -30.6% | 62,363 | +2.2% | 0.00% | – |
| Q3 2016 | $359,000 | +3.5% | 61,015 | -3.8% | 0.00% | – |
| Q2 2016 | $347,000 | +157.0% | 63,447 | +124.5% | 0.00% | – |
| Q1 2016 | $135,000 | +87.5% | 28,266 | +74.8% | 0.00% | – |
| Q4 2015 | $72,000 | – | 16,171 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| GAGNON SECURITIES LLC | 62,219 | $340,000 | 0.16% |
| THOMPSON DAVIS & CO., INC. | 16,184 | $89,000 | 0.14% |
| Blume Capital Management, Inc. | 2,546 | $14,000 | 0.01% |
| BLUESTEIN R H & CO LLC | 20,000 | $109,000 | 0.01% |
| Virtu KCG Holdings LLC | 49,157 | $269,000 | 0.01% |
| Spark Investment Management LLC | 11,000 | $60,000 | 0.01% |
| Spot Trading L.L.C | 62,300 | $341,000 | 0.01% |
| Acrospire Investment Management LLC | 1,270 | $7,000 | 0.01% |
| ACCURATE INVESTMENT SOLUTIONS, INC. | 1,000 | $5,000 | 0.01% |
| ARCADIA INVESTMENT MANAGEMENT CORP/MI | 1,819 | $10,000 | 0.00% |